|4Jun 2, 4:43 PM ET

Abdun-Nabi Daniel 4

4 · Aptevo Therapeutics Inc. · Filed Jun 2, 2023

Insider Transaction Report

Form 4
Period: 2023-06-01
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2023-06-01297298 total
    Common Stock (297 underlying)
  • Award

    Restricted Stock Unit

    2023-06-02+3,5713,571 total
    Common Stock (3,571 underlying)
  • Exercise/Conversion

    Common Stock

    2023-06-01+2974,768 total
Footnotes (3)
  • [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
  • [F2]On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.
  • [F3]The RSUs vest in full on the first anniversary of the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION